Cision PR Newswire

Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products

SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture...

WeFetch AI Corp. Is the New Name of GreenCore Solutions Corp.

gtinfetch.ai, WeFetch.ai's lead product, removes the guess from artificial intelligence (AI) shopping: the right...

USI Subsidiary Universal Optoelectronics Acquires Controlling Stake in Eugenlight Technologies, Advancing Optical Interconnect Industry Integration

SHANGHAI, Jan. 16, 2026 /PRNewswire/ -- USI announces that its wholly-owned subsidiary, Universal Optoeletronics Co., Ltd., completed the acquisition of a controlling stake in EugenLight...

Daqo New Energy’s Subsidiary Xinjiang Daqo Provides Preliminary Estimate of Net Loss for FY2025

SHANGHAI, Jan. 16, 2026 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy" or the "Company"), a leading manufacturer of high-purity polysilicon...

Metis “Starry Pro”: Achieving Greater Wealth Stability in a Changing Landscape.

HONG KONG, Jan. 16, 2026 /PRNewswire/ -- As we move into 2026, Metis Global (Cook Islands) Limited ("Metis CI"), a subsidiary of Metis Global Group,...